drug
as of 2026-07-01Mecamylamine
MeSH D008464
at a glance
small molecule
Pre-approval / investigational in the US
Developed by Massachusetts General Hospital
1 trials in the graph
Synthesized from structured facts only — each point cited above.
Mechanism & identity
Modality
small molecule
Indications
Investigational (via trials)
Trials
1
Study of the Effects of Mecamylamine and Varenicline in Schizophrenia
NCT00455650—Completed
KOLs & investigators
2
Facts & assertions
0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
developer
indication
indication
indication
KOL
A. Eden Evins, MD, MPH
personKOL score 5
Catherine Fullerton, M.D., M.P.H.
personKOL score —